Symptomatic Hallucal Interphalangeal Sesamoid Bones Successfully Treated With Ultrasound-Guided Injection – a Case Report -.
Symptomatic Hallucal Interphalangeal Sesamoid Bones Successfully Treated with Ultrasound-guided Injection – A Case Report -.
Korean J Pain. 2013 Apr; 26(2): 173-6
Shin HY, Park SY, Kim HY, Jung YS, An S, Kang do H
The hallucal interphalangeal sesamoid… Continue reading
Alcohol Use and Cerebral White Matter Compromise in Adolescence.
Alcohol use and cerebral white matter compromise in adolescence.
Addict Behav. 2013 Mar 15; 38(7): 2295-2305
Elofson J, Gongvatana W, Carey KB
Alcohol use is typically initiated during adolescence, a period known to be critical in neurodevelopment. The adolescent… Continue reading
A Prospective Study of Neurocognitive Changes 15 Years After Chronic Inhalant Abuse.
A prospective study of neurocognitive changes 15 years after chronic inhalant abuse.
Addiction. 2013 Mar 13;
Cairney S, O’ Connor N, Dingwall KM, Maruff P, Shafiq-Antonacci R, Currie J, Currie BJ
AIMS: In a previous study, neurological and cognitive deficits reflecting central nervous system (CNS) disruption from chronic inhalant abuse showed substantial recovery after 2 years’ abstinence. Functional recovery was progressive, with recovery rates dependent on the degree of impairment prior to abstinence, and severity and duration of initial abuse. Persistent deficits occurred in those with previous ‘lead encephalopathy’ from leaded petrol abuse. The current study examined recovery in the same cohort 15 years after baseline. DESIGN: Prospective cohort design. SETTING: Two remote Aboriginal communities in Arnhem Land, Australia. PARTICIPANTS: Using baseline group classifications, 27 healthy controls, 60 ex-chronic inhalant abusers and an additional 17 with previous lead encephalopathy were assessed. MEASUREMENTS: Standard neurological, ocular-motor and cognitive functions and blood lead levels. FINDINGS: Chronic (non-encephalopathic) inhalant abusers showed elevated blood lead levels and abnormal scores on most tasks at baseline. At 2 years’ abstinence, blood lead was reduced but remained elevated and most scores had normalized. By 15 years, blood lead and all performance scores were equivalent to healthy controls for this group (P?>?0.05). The encephalopathic group was more severely impaired… Continue reading
Melatonin and Its Agonists in Pain Modulation and Its Clinical Application.
Melatonin and its agonists in pain modulation and its clinical application.
Arch Ital Biol. 2012 Dec; 150(4): 274-92
Srinivasan V, Zakaria R, Jeet Singh H, Acuna-Castroviejo D
Melatonin, the hormone of darkness has many physiological functions in the body… Continue reading